← Back to Patent Explorer
US4246406A Expired / Lapsed US ⏱️ 0.0 years remaining

Heterocyclic substituted pyrazinoylguanidines

Assignee: Merck and Co Inc
•
Filing: 1979-03-27
•
Granted: 1981-01-20
•
Expires: 1999-03-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The case involves novel heterocyclic substituted pyrazinoylguanidines and a process for preparing same. The heterocyclic pyrazinoylguanidines are eukalemic agents possessing diuretic and natriuretic properties.

Inventors

  • 👤 Edward J. Cragoe, Jr.
  • 👤 Otto W. WOLTERSDORF, Jr.
  • 👤 Susan J. deSolms

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 19:29
CPC Classifications
C; C07; C07D; C07D241/00; C07D241/02; C07D241/10; C07D241/14; C07D241/24; C07D241/26; A; A61; A61P; A61P7/00; A61P7/10

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 91 words
A compound of the formula: ##STR6## wherein R 1 is hydrogen, lower alkyl having from 1 to 5 carbon atoms; R 2 is hydrogen, lower alkyl having 1 to 5 carbon atoms; R 3 is a 5 or 6 membered heterocyclic ring containing from 1 to 3 heterocyclic atoms selected from the elements N, O or S, said ring containing from 0 to 2 substituents selected from lower alkyl having 1 to 5 carbon atoms, halo, oxy or hydroxy; X is halo, and the pharmaceutically acceptable non-toxic acid addition salts thereof.
Claim 2
Dependent Claim 91 words
A compound of the formula: ##STR6## wherein R 1 is hydrogen, lower alkyl having from 1 to 5 carbon atoms; R 2 is hydrogen, lower alkyl having 1 to 5 carbon atoms; R 3 is a 5 or 6 membered heterocyclic ring containing from 1 to 3 heterocyclic atoms selected from the elements N, O or S, said ring containing from 0 to 2 substituents selected from lower alkyl having 1 to 5 carbon atoms, halo, oxy or hydroxy; X is halo, and the pharmaceutically acceptable non-toxic acid addition salts thereof.
Claim 3
Dependent Claim 81 words
A compound of the formula: ##STR7## wherein R 1 is hydrogen; R 2 is hydrogen or lower alkyl having from 1 to 3 carbon atoms; R 3 is a 5 or 6 membered heterocyclic ring containing from 1 to 3 heterocyclic atoms selected from the elements N, O or S, said ring containing from 0 to 2 substituents selected from lower alkyl having 1 to 5 carbon atoms, halo, oxy or hydroxy and the pharmaceutically acceptable non-toxic acid addition salts thereof.
Claim 4
Dependent Claim 81 words
A compound of the formula: ##STR7## wherein R 1 is hydrogen; R 2 is hydrogen or lower alkyl having from 1 to 3 carbon atoms; R 3 is a 5 or 6 membered heterocyclic ring containing from 1 to 3 heterocyclic atoms selected from the elements N, O or S, said ring containing from 0 to 2 substituents selected from lower alkyl having 1 to 5 carbon atoms, halo, oxy or hydroxy and the pharmaceutically acceptable non-toxic acid addition salts thereof.
Claim 5
Dependent Claim 10 words
A compound of claim 1 wherein R 3 is ##STR8##
Claim 6
Dependent Claim 21 words
A compound of claim 2 wherein R 1 is hydrogen; R 2 is hydrogen; R 3 is ##STR9## to yield 3,5-diamino-6-chloro-N-[(2-thiazolinylamino)aminomethylene]-2-pyrazinecarboxamide.
Claim 7
Dependent Claim 21 words
A compound of claim 2 wherein R 1 is hydrogen; R 2 is isopropyl; R 3 is ##STR10## to yield 3-amino-6-chloro-5-isopropylamino-N-[(2-thiazolinylamino)aminomethylene]-2-pyrazinecarboxamide.
Claim 8
Dependent Claim 21 words
A compound of claim 2 wherein R 1 is hydrogen; R 2 is hydrogen; R 3 is ##STR11## to yield 3,5-diamino-6-chloro-N-[(2-oxazolinylamino)aminomethylene]-2-pyrazinecarboxamide.
Claim 9
Dependent Claim 21 words
A compound of claim 2 wherein R 1 is hydrogen; R 2 is hydrogen; R 3 is ##STR12## to yield 3,5-diamino-N-[(2-thiazolylamino)aminomethylene]-6-chloro-2-pyrazinecarboxamide.
Claim 10
Dependent Claim 23 words
A compound of claim 2 wherein R 1 is hydrogen; R 2 is hydrogen; R 3 is ##STR13## to yield 3,5-diamino-6-chloro-N-{[2-(4,5-dihydro)thiazinylamino]aminomethylene}-2-pyrazinecarboxamide hydrochloride hemihydrate.

References Cited (Backward Citations)

US3328404A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-01-20 1984-07-21 1985-01-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-01-20 1988-07-21 1989-01-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-01-20 1992-07-21 1993-01-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag